Estimating The Intrinsic Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)

Key Insights Guangxi LiuYao Group's estimated fair value is CN¥21.40 based on 2 Stage Free Cash Flow to Equity Guangxi LiuYao Group's CN¥21.18 share price indicates it is trading at similar levels a

Simply Wall St18:06 ET

Liu Pharmaceutical Group (603368.SH): Net profit increased 20.7% year-on-year in 2023

Gelonghui, March 19丨Liuyao Group (603368.SH) announced its 2023 annual results report. During the reporting period, the company achieved total operating revenue of 208,011.9029 million yuan, an increase of 9.23% over the previous year; net profit attributable to shareholders of listed companies was 8467.639 million yuan, an increase of 20.70% over the previous year. In the pharmaceutical wholesale sector, the company strengthens supplier cooperation, seizes high-quality new products, actively expands SPD projects for pharmaceutical consumables, promotes the implementation of the collection and distribution model, and steadily increases the size of the wholesale market, especially the market share of equipment consumables. In the pharmaceutical retail sector, the company continues to expand to zero

Gelonghui FinanceMar 19 04:13 ET

Liu Pharmaceutical Group (603368.SH)'s net profit for 2023 was 847 million yuan, up 20.7% year on year

Liu Pharmaceutical Group (603368.SH) released its 2023 annual performance report. The company's total revenue was 208.12...

Zhitong FinanceMar 19 04:11 ET

Investors Aren't Buying Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Earnings

With a price-to-earnings (or "P/E") ratio of 8.6x Guangxi LiuYao Group Co., Ltd (SHSE:603368) may be sending very bullish signals at the moment, given that almost half of all companies in China have P

Simply Wall StFeb 23 21:09 ET

Retail Investors Who Hold 42% of Guangxi LiuYao Group Co., Ltd (SHSE:603368) Gained 6.7%, Insiders Profited as Well

Key Insights The considerable ownership by retail investors in Guangxi LiuYao Group indicates that they collectively have a greater say in management and business strategy 50% of the business is hel

Simply Wall StJan 29 17:32 ET

These 4 Measures Indicate That Guangxi LiuYao Group (SHSE:603368) Is Using Debt Reasonably Well

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will

Simply Wall StJan 10 19:44 ET